יחס חוב לטווח קצר להון עצמי: NeurAxis, Inc. (NRXS)

NeurAxis, Inc. (NRXS) is protected by unique patents for electrical stimulators for children with gastrointestinal disorders, which, combined with strict FDA oversight, limits competition. This price action chart demonstrates a metric at 0.02 as the firm implements recyclable polymers and remote diagnostics. The company's operations focus on the eco-friendly disposal of electronics and strict energy conservation within its neuro-device assembly plants.

Fundamental asset selection requires an analysis of debt load to assess business resilience to external shocks. This indicator measures the proportion of liabilities with a maturity of over one year relative to equity, which allows the short-term leverage chart to evaluate the risk of NeurAxis, Inc. (NRXS) dependency on borrowings while implementing a pricing power strategy in the market for unique neurostimulation systems.